Hormonal therapy and radiation therapy in prostate cancer: 5-year outcomes from a trial evaluating combined androgen blockade with 5-alpha reductase inhibitors as an alternative to gonadotropin releasing hormone agonists
Article in Clinical Genitourinary Cancer (April 2024)